Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd
1 clinical trials · Sponsor
◉ Watch Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd
| Record | Firm | Date |
|---|---|---|
| Clinical Study of SYS6055 Injection in Participants With Relapsed/Refractory Aggressive B-Cell Lymphoma (NCT07476066) | Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd | 2026-03-15 |
Track Beijing Kangchuanglian Biopharmaceutical Technology Research Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.